Open Save New
FeedNavigator / National Library of Health Sciences
 
  
Tutkijat / Institutions
AddAarnio, M(arkku) (KSSHP)
AddAlafuzoff, I. (Uppsala)
AddAro, A. (THL)
AddAromaa, A. (THL)
AddArvas, M(ikko) (Veripalvelu)
AddBamford, D.H. (UH Viikki Campus)
AddButcher, S. (UH Viikki Campus)
AddCerullo, V. (UH Viikki Campus)
AddEkblom-Kullberg, S(usanne) (Veripalvelu)
AddEskola, J. (THL)
AddFinel, M(oshe) (UH Viikki Campus)
AddGahmberg, C.G. (UH Viikki Campus)
AddHaimila, K(atri) (Veripalvelu)
AddHäkkinen, U. (THL)
AddHanski, I(lkka) (1953-2016) (UH Viikki Campus)
AddHari, R. (Aalto)
AddHavulinna, A(ki) S. (THL)
AddHemminki, E. (THL)
AddHiltunen, L(eena) (Veripalvelu)
AddHiltunen, R(aimo) (UH Viikki Campus)
AddHolthöfer, H. (CBAS, Dublin)
AddHovi, T. (THL)
AddHuoponen, O(uti) (Veripalvelu)
AddHuovinen, P. (THL)
AddHyytiä, P. (THL)
AddImpola, U(lla) (Veripalvelu)
AddJaatinen, T(aina) (Veripalvelu)
AddJacobs, H.T. (UH Viikki Campus)
AddJalanko, A. (THL)
AddJalkanen, J(yrki) (KSSHP)
AddJantunen, M. (THL)
AddJavela, K(aija) (Veripalvelu)
AddJoensuu, T(imo) (Docrates Cancer Center)
AddJokela, J(orma) (Laurea)
AddJokitalo, E. (UH Viikki Campus)
AddJousilahti, P(ekka) (THL)
AddJulkunen, I. (THL)
AddJuppo, A(nne) (UH Viikki Campus)
AddKääriäinen, H. (THL)
AddKaartinen, T(anja) (Veripalvelu)
AddKairemo, K(alevi) (Docrates)
AddKallioniemi, O(lli) (SciLifeLab)
AddKarvonen, M. (THL)
AddKayhty, H. (THL)
AddKerkelä, E(rja) (Veripalvelu)
AddKeskimäki, I. (THL)
AddKiianmaa, K. (THL)
AddKinnunen, P.K. (Aalto)
AddKirjavainen, V(esa) (Veripalvelu)
AddKlaukka, T. (Kela)
AddKorhonen, M(atti) (Veripalvelu)
AddKoskela, S(atu) (Veripalvelu)
AddKoskinen, S(eppo) (THL)
AddKovanen, P.T. (Wihuri)
AddKyrölä, K(ati) (KSSHP)
AddLaatikainen, T(iina) (THL)
AddLähteenmäki, K(aarina) (Veripalvelu)
AddLaitinen, S(aara) (Veripalvelu)
AddLappalainen, P. (UH Viikki Campus)
AddLarjo, A(ntti) (Veripalvelu)
AddLauronen, J(ouni) (Veripalvelu)
AddLehtinen, M(atti) (THL)
AddLeino-Arjas, P. (TTL)
AddLeinonen, M. (THL)
AddLindros, K. (THL)
AddLinjama, T(iina) (Veripalvelu)
AddLönnqvist, J. (THL)
AddMäkelä, M. (THL)
AddMäkelä, P.H. (THL)
AddMalmivaara, A(ntti) (THL)
AddMännistö, P. (UH Viikki Campus)
AddMattila, P. (PSHP)
AddMattila, P(irkko) (Veripalvelu/FIMM)
AddMättö, J(aana) (Veripalvelu)
AddNatunen, S(uvi) (Veripalvelu)
AddNissinen, A. (THL)
AddNystedt, J(ohanna) (Veripalvelu)
AddOvaskainen. M.L (THL).
AddPalosuo, T. (THL)
AddPalva, A(iri) (UH Viikki Campus)
AddPartanen, J(ukka) (Veripalvelu)
AddPartonen, T. (THL)
AddPatja, K. (THL)
AddPeltonen, M(arkku) (THL)
AddPeräsaari, J(uha) (Veripalvelu)
AddPietinen, P. (THL)
AddPrattala, R. (THL)
AddPuska, P. (THL)
AddQiao, Q(ing) (THL)
AddReunanen, A. (THL)
AddRiihimäki, H. (TTL)
AddRitari, J(armo) (Veripalvelu)
AddRuotsalainen, P. (THL)
AddRuskoaho, H(eikki) (UH Viikki Campus)
AddRuutu, P. (THL)
AddSaarma, M. (UH Viikki Campus)
AddSaarni, S.I. (THL)
AddSaikku, P. (THL)
AddSainio, S(usanna) (Veripalvelu)
AddSalomaa, V(eikko) (THL)
AddShimmi, O. (UH Viikki Campus)
AddSiitonen, A. (THL)
AddSolantaus, T. (THL)
AddThesleff, I. (UH Viikki Campus)
AddTuomisto, J. (THL)
AddUutela, A. (THL)
AddVaarala, O. (THL)
AddValsta, L. (THL)
AddVartiainen, E(rkki) (THL)
AddVartiainen, T. (THL)
AddVasankari, T(ommi) (UKK)
AddViikari-Juntura, E. (TTL)
AddVirtamo, J. (THL)
AddVirtanen, S.M. (THL)
AddVuopio, J. (THL)
AddWahlbeck, K. (THL)
AddWikström, M. (UH Viikki Campus)

Scholar Chart >>



»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
Genetic Risk Score for Serum 25-Hydroxyvitamin D Concentration Helps to Guide Personalized Vitamin D Supplementation in Healthy Finnish Adults.Kallioniemi, O(lli) (SciLifeLab)125 dayssaveRefWorks
Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness.Kallioniemi, O(lli) (SciLifeLab)218 dayssaveRefWorks
KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.Kallioniemi, O(lli) (SciLifeLab)292 dayssaveRefWorks
Publisher Correction: Building an international consortium for tracking coronavirus health status.Kallioniemi, O(lli) (SciLifeLab)312 dayssaveRefWorks
Building an international consortium for tracking coronavirus health status.Kallioniemi, O(lli) (SciLifeLab)336 dayssaveRefWorks
Breeze: an integrated quality control and data analysis application for high-throughput drug screening.Kallioniemi, O(lli) (SciLifeLab)429 dayssaveRefWorks
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival.Kallioniemi, O(lli) (SciLifeLab)469 dayssaveRefWorks
Multi-parametric single cell evaluation defines distinct drug responses in healthy hematological cells that are retained in corresponding malignant cell types.Kallioniemi, O(lli) (SciLifeLab)621 dayssaveRefWorks
Fibroblast as a critical stromal cell type determining prognosis in prostate cancer.Kallioniemi, O(lli) (SciLifeLab)672 dayssaveRefWorks
Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML.Kallioniemi, O(lli) (SciLifeLab)697 dayssaveRefWorks
Individual and stable autoantibody repertoires in healthy individuals.Kallioniemi, O(lli) (SciLifeLab)792 dayssaveRefWorks
Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.Kallioniemi, O(lli) (SciLifeLab)813 dayssaveRefWorks
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL.Kallioniemi, O(lli) (SciLifeLab)844 dayssaveRefWorks
Anagrelide for gastrointestinal stromal tumor.Kallioniemi, O(lli) (SciLifeLab)876 dayssaveRefWorks
Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer.Kallioniemi, O(lli) (SciLifeLab)894 dayssaveRefWorks
Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.Kallioniemi, O(lli) (SciLifeLab)923 dayssaveRefWorks
T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma.Kallioniemi, O(lli) (SciLifeLab)957 dayssaveRefWorks
Association of tamoxifen resistance and lipid reprogramming in breast cancer.Kallioniemi, O(lli) (SciLifeLab)984 dayssaveRefWorks
Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells.Kallioniemi, O(lli) (SciLifeLab)989 dayssaveRefWorks
PD-L1+ tumor-associated macrophages and PD-1+ tumor infiltrating lymphocytes predict survival in primary testicular lymphoma.Kallioniemi, O(lli) (SciLifeLab)1019 dayssaveRefWorks
Drug sensitivity screening and genomic characterization of 45 HPV-negative head and neck carcinoma cell lines for novel biomarkers of drug efficacy.Kallioniemi, O(lli) (SciLifeLab)1036 dayssaveRefWorks
Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML.Kallioniemi, O(lli) (SciLifeLab)1049 dayssaveRefWorks
Prognostic, predictive and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.Kallioniemi, O(lli) (SciLifeLab)1056 dayssaveRefWorks
Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemia.Kallioniemi, O(lli) (SciLifeLab)1127 dayssaveRefWorks
Spatial Aspects of Oncogenic Signaling Determine Response to Combination Therapy in Slice Explants from Kras-driven Lung Tumors.Kallioniemi, O(lli) (SciLifeLab)1176 dayssaveRefWorks
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer.Kallioniemi, O(lli) (SciLifeLab)1184 dayssaveRefWorks
Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours.Kallioniemi, O(lli) (SciLifeLab)1192 dayssaveRefWorks
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma.Kallioniemi, O(lli) (SciLifeLab)1218 dayssaveRefWorks
Colorectal cancer Consensus Molecular Subtypes translated to preclinical models uncover potentially targetable cancer-cell dependencies.Kallioniemi, O(lli) (SciLifeLab)1237 dayssaveRefWorks
Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis.Kallioniemi, O(lli) (SciLifeLab)1267 dayssaveRefWorks
Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.Kallioniemi, O(lli) (SciLifeLab)1275 dayssaveRefWorks
The impact of RNA sequence library construction protocols on transcriptomic profiling of leukemia.Kallioniemi, O(lli) (SciLifeLab)1356 dayssaveRefWorks
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.Kallioniemi, O(lli) (SciLifeLab)1360 dayssaveRefWorks
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.Kallioniemi, O(lli) (SciLifeLab)1418 dayssaveRefWorks
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors (MPNST).Kallioniemi, O(lli) (SciLifeLab)1436 dayssaveRefWorks
PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells.Kallioniemi, O(lli) (SciLifeLab)1467 dayssaveRefWorks
Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response.Kallioniemi, O(lli) (SciLifeLab)1497 dayssaveRefWorks
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.Kallioniemi, O(lli) (SciLifeLab)1544 dayssaveRefWorks
Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.Kallioniemi, O(lli) (SciLifeLab)1566 dayssaveRefWorks
Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1.Kallioniemi, O(lli) (SciLifeLab)1568 dayssaveRefWorks
High-throughput RNAi screening identifies sensitizing targets to improve doxorubicin chemotherapy.Kallioniemi, O(lli) (SciLifeLab)1590 dayssaveRefWorks
Consistency in drug response profiling.Kallioniemi, O(lli) (SciLifeLab)1615 dayssaveRefWorks
High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.Kallioniemi, O(lli) (SciLifeLab)1619 dayssaveRefWorks
Enhanced sensitivity to glucocorticoids in cytarabine resistant AML.Kallioniemi, O(lli) (SciLifeLab)1635 dayssaveRefWorks
Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia.Kallioniemi, O(lli) (SciLifeLab)1647 dayssaveRefWorks
KeepEX, a simple dilution protocol for improving extracellular vesicle yields from urine.Kallioniemi, O(lli) (SciLifeLab)1654 dayssaveRefWorks
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling.Kallioniemi, O(lli) (SciLifeLab)1656 dayssaveRefWorks
Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization.Kallioniemi, O(lli) (SciLifeLab)1706 dayssaveRefWorks
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.Kallioniemi, O(lli) (SciLifeLab)1731 dayssaveRefWorks
Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.Kallioniemi, O(lli) (SciLifeLab)1739 dayssaveRefWorks
 XML / RSS feed
report
next »